Everpar Advisors LLC Boosts Stock Position in CME Group Inc. (NASDAQ:CME)

Everpar Advisors LLC lifted its position in CME Group Inc. (NASDAQ:CME) by 34.0% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 1,526 shares of the financial services provider’s stock after buying an additional 387 shares during the quarter. Everpar Advisors LLC’s holdings in CME Group were worth $300,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Gold Investment Management Ltd. purchased a new stake in shares of CME Group in the 4th quarter valued at $26,000. Salomon & Ludwin LLC acquired a new position in CME Group during the 1st quarter worth $28,000. Northwest Financial Advisors acquired a new position in CME Group during the 4th quarter worth $28,000. Rise Advisors LLC acquired a new position in CME Group during the 1st quarter worth $41,000. Finally, McClarren Financial Advisors Inc. grew its stake in CME Group by 89.5% during the 1st quarter. McClarren Financial Advisors Inc. now owns 216 shares of the financial services provider’s stock worth $47,000 after purchasing an additional 102 shares in the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently commented on CME shares. Barclays boosted their target price on CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a research note on Thursday, July 25th. Rosenblatt Securities reissued a “sell” rating and set a $187.00 target price (up from $185.00) on shares of CME Group in a research note on Thursday, April 25th. Keefe, Bruyette & Woods boosted their target price on CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a research note on Thursday, July 25th. JPMorgan Chase & Co. upped their price objective on CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research report on Thursday, July 25th. Finally, Piper Sandler lowered their price objective on CME Group from $235.00 to $225.00 and set an “overweight” rating for the company in a research report on Thursday, July 25th. Three research analysts have rated the stock with a sell rating, six have given a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $213.27.

Insider Buying and Selling at CME Group

In other CME Group news, Director Charles P. Carey sold 3,000 shares of the company’s stock in a transaction that occurred on Thursday, June 13th. The stock was sold at an average price of $195.44, for a total transaction of $586,320.00. Following the completion of the sale, the director now directly owns 7,163 shares of the company’s stock, valued at approximately $1,399,936.72. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other CME Group news, Director Charles P. Carey sold 3,000 shares of the company’s stock in a transaction that occurred on Thursday, June 13th. The stock was sold at an average price of $195.44, for a total transaction of $586,320.00. Following the completion of the sale, the director now directly owns 7,163 shares of the company’s stock, valued at approximately $1,399,936.72. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Daniel R. Glickman sold 650 shares of the company’s stock in a transaction that occurred on Thursday, June 6th. The shares were sold at an average price of $201.44, for a total value of $130,936.00. Following the sale, the director now directly owns 14,008 shares of the company’s stock, valued at $2,821,771.52. The disclosure for this sale can be found here. Insiders sold a total of 4,650 shares of company stock valued at $928,776 in the last ninety days. Insiders own 0.30% of the company’s stock.

CME Group Stock Performance

Shares of NASDAQ CME traded up $2.59 during trading hours on Friday, reaching $207.88. The stock had a trading volume of 1,115,669 shares, compared to its average volume of 1,947,617. The firm has a market cap of $74.85 billion, a price-to-earnings ratio of 23.65, a PEG ratio of 6.27 and a beta of 0.52. The company has a current ratio of 1.02, a quick ratio of 1.01 and a debt-to-equity ratio of 0.10. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $223.80. The firm has a 50-day moving average of $198.53 and a 200-day moving average of $207.05.

CME Group (NASDAQ:CME) last announced its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. The firm had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The business’s revenue was up 12.7% on a year-over-year basis. During the same period in the prior year, the firm earned $2.30 EPS. Equities research analysts predict that CME Group Inc. will post 9.8 earnings per share for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th will be paid a dividend of $1.15 per share. This represents a $4.60 annualized dividend and a yield of 2.21%. The ex-dividend date of this dividend is Monday, September 9th. CME Group’s dividend payout ratio is presently 52.33%.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.